Medicenna Therapeutics Company
Medicenna is a clinical stage, privately held, immuno-oncology company.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Canada
Founded Date:
2012
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
$7.5M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership